Internal Medicine, Rheumatology · Westfield, IN
NPI
1417998626
Since 2006
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
3501 Westfield Rd Ste 101
Westfield, IN, 46062
Phone (317) 214-6020
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.2M
76,389 services
Medicare patients, 2024
176
Average age 69
Drug cost, 2024
$3.8M
2,590 prescriptions
Company payments, 2025
$929
From 15 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Trinh T Tran was code J3262 (injection, tocilizumab, 1 mg), 33,960 times for 13 patients. In total Trinh T Tran billed 76,389 services in 35 codes, and Medicare paid $1.2M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-05-30.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J3262 Injection, tocilizumab, 1 mg | Office | 33,960 | 13 | $4.70 | $160K |
| J0129 Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 16,300 | 25 | $33.88 | $552K |
| J9312 Injection, rituximab, 10 mg | Office | 4,200 | 11 | $37.17 | $156K |
| J0897 Injection, denosumab, 1 mg | Office | 2,520 | 26 | $20.54 | $52K |
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 1,904 | 20 | $0.10 | $188 |
| 96413 Chemotherapy Administration | Office | 371 | 51 | $86.72 | $32K |
| 99214 Office E&M - Established | Office | 204 | 120 | $80.74 | $16K |
| 96415 Chemotherapy Administration | Office | 143 | 12 | $17.70 | $2,531 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 137 | 100 | $11.98 | $1,641 |
| 99215 Office E&M - Established | Office | 90 | 67 | $118.59 | $11K |
| 96401 Chemotherapy Administration | Office | 74 | 28 | $51.39 | $3,803 |
| 96375 Injection Administration | Office | 42 | 14 | $10.35 | $435 |
| 96372 Injection Administration | Office | 37 | 23 | $10.29 | $381 |
| 99205 Office E&M - New | Office | 29 | 29 | $146.09 | $4,237 |
| 99213 Office E&M - Established | Office | 25 | 20 | $67.40 | $1,685 |
By year: 2022 $1.9M for 89,837 services; 2023 $1.3M for 83,119 services; 2024 $1.2M for 76,389 services.
Medicare prescription drug claims, 2024
In 2024, the drug Trinh T Tran prescribed most often to Medicare patients was Hydroxychloroquine Sulfate, with 469 prescriptions and refills. In total Trinh T Tran wrote 2,590 Medicare prescriptions that cost $3.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydroxychloroquine Sulfate Generic | 469 | 1,260 | 167 | $22K |
| Prednisone Generic | 196 | 407 | 82 | $1,410 |
| Tramadol Hcl Generic | 141 | 141 | 27 | $1,639 |
| Nystatin Generic | 140 | 160 | 88 | $4,907 |
| Leflunomide Generic | 103 | 230 | 35 | $9,100 |
| Methotrexate Methotrexate Sodium | 102 | 258 | 39 | $3,465 |
| Rinvoq Upadacitinib | 99 | 99 | 12 | $625K |
| Alendronate Sodium Generic | 90 | 203 | 35 | $627 |
| Orencia Clickject Abatacept | 85 | 85 | Under 11 | $486K |
| Famotidine Generic | 76 | 175 | 24 | $931 |
| Azathioprine Generic | 56 | 125 | 18 | $1,322 |
| Methylprednisolone Generic | 54 | 62 | 38 | $580 |
| Fluconazole Generic | 53 | 76 | 44 | $1,139 |
| Gabapentin Generic | 44 | 121 | 21 | $713 |
| Xeljanz Xr Tofacitinib Citrate | 34 | 34 | Under 11 | $197K |
Brand drugs: 559 claims; generic drugs: 2,031 claims; opioid claims: 161.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Trinh T Tran $929 ($929 in general payments such as food, travel and fees) from 15 companies. The largest payer was Amgen Inc. with $177.
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. AMGN | 13 | $177 |
| Pfizer Inc. PFE | 12 | $154 |
| Genzyme Corporation SNY | 1 | $144 |
| AstraZeneca Pharmaceuticals LP AZN | 5 | $109 |
| Novartis Pharmaceuticals Corporation NVS | 5 | $99.24 |
| Aurinia Pharma U.S., Inc. AUPH | 2 | $39.83 |
| Lilly USA, LLC LLY | 2 | $39.52 |
| Mallinckrodt Hospital Products Inc. | 2 | $35.01 |
| Abbvie Inc. ABBV | 1 | $29.51 |
| Octapharma USA, Inc. | 1 | $24.15 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.